Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease
Clinical trial NCT04795466 · TERMINATED
Trial details
- NCT number
- NCT04795466
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-28
- Primary completion
- 2024-03-07
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.